Tradestie Institutional Equity Comparison Engine

GNL vs SBRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SBRA Overall Edge

SBRA Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sabra Healthcare REIT, Inc. (SBRA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GNL trades at N/M Forward P/E with 34.8% operating margin (-6.7% YoY revenue) versus SBRA at 30.4x Forward P/E and 18.4% operating margin (+31.6% YoY). In options structure, GNL sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against SBRA sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SBRA
GNL N/M vs SBRA 30.4x Fwd P/E
Growth & Margin Winner SBRA
Op Margin 34.8% vs 18.4% ยท YoY -6.7% vs +31.6%
Momentum & Technical Winner SBRA
1Y -21.0% vs +8.6% ยท 52W Pos 1% vs 52%
Options & Structure Winner SBRA
UNCLASSIFIED (100th %ile IV) vs CONSOLIDATION (17th %ile IV)
GNL NYSE
Global Net Lease, Inc.
Real Estate Investment Trusts
$6.28
-2.71% 1D
Market Cap $1.5B
1M Return -14.28%
1Y Return -20.97%
Forward P/E N/M
Unified AI Score
35.5 / 100 SELL
Tech 25.0 Fund 38.0 Flow 50.0 Mom 45.0
SBRA NASDAQ
Sabra Healthcare REIT, Inc.
Real Estate Investment Trusts
$20.25
-0.47% 1D
Market Cap $5.4B
1M Return +6.16%
1Y Return +8.61%
Forward P/E 30.4x
Unified AI Score
57.4 / 100 HOLD
Tech 49.0 Fund 57.0 Flow 57.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GNL -20.97% SBRA +8.61% Spread: +29.58 pp (SBRA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GNL TTM Op. Margin: 34.8% SBRA TTM Op. Margin: 18.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNL vs SBRA. Trailing 12-month operating profitability (GNL 34.8% vs SBRA 18.4%) and valuation multiples (GNL N/M vs SBRA 30.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GNL (2) vs SBRA (8)
Institutional Metric GNL SBRA Criterion Row Winner
Market Capitalization Scale $1.5B $5.4B Larger Scale SBRA
Trailing P/E Ratio Valuation N/M 75.7x Lower Multiple SBRA
Forward P/E Ratio Valuation N/M 30.4x Lower Multiple SBRA
Revenue Growth (YoY) Growth -6.7% +31.6% Higher Growth SBRA
Operating Margin (TTM) Profitability 34.8% 18.4% Higher Margin GNL
Net Profit Margin Profitability -2.1% 7.7% Higher Margin SBRA
Return on Equity (ROE) Capital Efficiency -0.8% 2.5% Higher ROE SBRA
52-Week Range Position Momentum 1% ($6โ€“$10) 52% ($18โ€“$23) Stronger Trend SBRA
Beta / 30D Volatility Risk Regime 0.21ฮฒ ยท 29% Vol 0.00ฮฒ ยท 30% Vol Lower Realized Risk GNL
Unified Institutional Score Composite Signal 35.5 / 100 (SELL) 57.4 / 100 (HOLD) Higher Composite SBRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GNL vs SBRA Buy Guide
GNL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live GNL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SBRA CONSOLIDATION
80d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live SBRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GNL nor SBRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.